Saturna Capital CORP

SEC CIK: 0001316617
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

HZNP holding history

Horizon Therapeutics Public Ltd Co in every 13F filed by Saturna Capital CORP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HZNP overview All 13F holders of HZNP Full Q2 2026 holdings

Shares (Q1 2023): 0; Sold out in Q1 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q2 2022

Holdings of HZNP by Saturna Capital CORP, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2023	0	$0	0.0%	−17,325−100.0%	Sold out	Holders
Q4 2022	17,325	$1.97M	<0.1%	−675−3.8%	Reduced	Holders
Q3 2022	18,000	$1.11M	<0.1%	−3,300−15.5%	Reduced	Holders
Q2 2022	21,300	$1.70M	<0.1%	+21,300	New	Holders